Workshop Background and Objectives

Transcription

1 International Tobacco Control Workshop March 24 26, 2015 Ankara, Turkey Workshop Background and Objectives Turkey has become a regional leader in tobacco control and is the first country in the world to fully implement all five WHO MPOWER measures to protect people from tobacco smoke. A ban on smoking in all indoor workplaces and public spaces; a comprehensive ban on tobacco advertising, promotion, and sponsorship; and graphic warning labels are some of the key measures that have been introduced. Thus far, preliminary evidence suggests that these measures have been successful in reducing smoking prevalence, secondhand smoke exposure, and related health and economic costs. Turkey also hosted the European Conference on Tobacco or Health in March The workshop objectives are to support research capacity in tobacco control in Turkey and the neighboring region while building greater collaboration among U.S., Turkish, and regional tobacco control specialists and government representatives. The agenda addresses current research activities in Turkey; research gaps and needs in Turkey and the region; tobacco research funding mechanisms, including NCI/NIH and other agencies; 50 years of progress in tobacco control in the United States; experience from U.S.-funded investigators in capacity-building and international research; and a discussion of recommendations for collaborative research activities. List of Acronyms CiPHR Center for Innovative Public Health Research FCTC Framework Convention on Tobacco Control FDA Food and Drug Administration (U.S.) GNAT Grand National Assembly of Turkey MOH Ministry of Health NCI National Cancer Institute (U.S.) NIH National Institutes of Health (U.S.) Q&A Question-and-Answer TAPDK Tobacco and Alcohol Market Regulatory Authority (Turkey) TÜBITAK Scientific and Technological Research Council of Turkey UICC Union of International Cancer Control WHO World Health Organization (International) 1

2 Agenda Master of Ceremony: Dr. Burcu Küçük Biçer, Hacettepe University, Turkey Day 1 8:30 a.m. 5:10 p.m. 8:30 a.m. 9:00 a.m. Participant Registration 9:00 a.m. 9:45 a.m. Welcome and Introductions NCI, NIH; WHO; MOH, Turkey; TAPDK; Hacettepe University; and GNAT Dr. Mark Parascandola, Epidemiologist, Tobacco Control Research Branch, NCI, NIH Mr. Y. Mehmet Kontas, Acting Head, WHO Country Office in Turkey Dr. Bekir Keskinkılıç, Vice President of Turkish Public Health Institution and Head of Non-Communicable Diseases, Woman and Child Health Branch, Ministry of Health, Turkey Mr. Seyit Ali Kurtuluş, Acting President, Tobacco and Alcohol Market Regulatory Authority, Turkey Prof. Dr. A. Murat Tuncer, Rector, Hacettepe University, Turkey Prof. Dr. Cevdet Erdöl, Member of Parliament (Ankara), Former President of Health, Family, Labor and Social Affairs Commission, Grand National Assembly of Turkey 9:45 a.m. 10:00 a.m. Coffee and Tea Break 10:00 a.m. 10:30 a.m. Outline and Objectives for the Workshop and Regional Participants Brief Introduction 10:30 a.m. 10:50 a.m. Evaluating Progress Toward FCTC Implementation (Skype) Kristina Mauer-Stender, WHO 10:50 a.m. 12:20 p.m. Session 1: Tobacco Control Progress in Turkey Chair: Tezer Kutluk, UICC 10:50 a.m. 11:10 a.m. Patterns of Tobacco Use Prevalence in Turkey Nazmi Bilir, Hacettepe University 11:10 a.m. 11:30 a.m. Tobacco Control Activities in Turkey Sertaç Polat, Head of Department of Tobacco and Addictive Substances, Turkey 11:30 a.m. 11:50 a.m. Future Steps and Challenges of the Tobacco Control Program L. Hilal Özcebe, Hacettepe University 11:50 a.m. 12:20 p.m. Discussion and Q&A Session 2

3 12:20 p.m. 1:20 p.m. Lunch 1:20 p.m. 3:10 p.m. Session 2: U.S. Experience 50 Years of the Tobacco Epidemic Chair: Ismail Çelik, Hacettepe University 1:20 p.m. 1:40 p.m. Lessons From 50 Years of Tobacco Control Efforts 1:40 p.m. 2:00 p.m. Measuring Progress and the Impact of Tobacco Control Policies David Levy, Georgetown University 2:00 p.m. 2:20 p.m. Tobacco Regulatory Science Cathy Backinger, FDA 2:20 p.m. 2:40 p.m. Tobacco Cessation: Best Practices Scott Leischow, Mayo Clinic 2:40 p.m. 3:10 p.m. Discussion and Q&A Session 3:10 p.m. 3:20 p.m. Coffee and Tea Break 3:20 p.m. 5:10 p.m. Session 3: Research Topics Chair: Ayşe Gökalp Kırca Çelik, TAPDK 3:20 p.m. 3:40 p.m. Methods for the Measurement and Control of Illicit Tobacco Products (Skype) Mark Goodchild, WHO 3:40 p.m. 4:00 p.m. Tobacco Packaging, Labeling, and Promotion Jim Thrasher, University of South Carolina 4:00 p.m. 4:20 p.m. Measuring Tobacco Product Emissions Mirjana Djordjevic, NCI, NIH 4:20 p.m. 4:40 p.m. E-Cigarettes General Overview Rachel Grana, NCI, NIH 4:40 p.m. 5:10 p.m. Discussion and Q&A Session 5:10 p.m. Adjourn for the Day Day 2 9:00 a.m. 4:50 p.m. 9:00 a.m. 11:10 a.m. Session 4: Models of Research Collaboration Chair: Mutlu Hayran, Hacettepe University 3

4 9:00 a.m. 9:20 a.m. Overview and Objectives for the Day Marie Ricciardone, NCI, NIH 9:20 a.m. 9:40 a.m. mcessation in Turkey Michele Ybarra, CiPHR, and Aslı Çarkoğlu, Kadir Has University; 9:40 a.m. 10:00 a.m. Quit Tobacco International: Overview and Lessons Learned in India and Indonesia Mimi Nichter, University of Arizona 10:00 a.m. 10:20 a.m. Cessation Research in Turkey Mimi Nichter, University of Arizona, and Asli Çarkoğlu, Kadir Has University 10:20 a.m. 10:40 a.m. WHO Tobacco Laboratory Network Gemma Vestal, WHO 10:40 a.m. 11:10 a.m. Discussion and Q&A Session 11:10 a.m. 11:20 a.m. Coffee and Tea Break 11:20 a.m. 12:20 p.m. Discussion Panel: Challenges and Opportunities for Building Research Networks and Collaborations Around Tobacco Control Discussants: Michele Ybarra, CiPHR; Salih Emri, Hacettepe University; Asli Çarkoğlu, Kadir Has University; and Scott Leischow, Mayo Clinic Facilitators: Mutlu Hayran, Hacettepe University, and Mark Parascandola, NCI, NIH 12:20 p.m. 1:20 p.m. Lunch 1:20 p.m. 2:20 p.m. Session 5: Funding Mechanisms for Tobacco Control Research and Training Chair: Rachel Grana, NCI, NIH 1:20 p.m. 1:40 p.m. NIH Research Portfolio in Tobacco Control and Cancer Prevention 1:40 p.m. 2:00 p.m. TÜBITAK Funding Opportunities Güliz Sütçü, TÜBİTAK 4

5 2:00 p.m. 2:20 p.m. Opportunities for Non-Governmental Funding Toker Ergüder, WHO 2:20 p.m. 3:00 p.m. Global Tobacco Control Funders: Research for Action Discussants: ; Toker Ergüder, WHO; Cathy Backinger, FDA; and Tezer Kutluk, UICC Facilitator: Tezer Kutluk, UICC 3:00 p.m. 3:10 p.m. Coffee and Tea Break 3:10 p.m. 4:50 p.m. Session 6: Research Capacity-Building Needs Assessment Chair: Marie Ricciardone, NCI, NIH 3:10 p.m. 3:50 p.m. Country-Specific Assessments of Tobacco Control Toker Ergüder, WHO 3:50 p.m. 4:50 p.m. Research Capacity-Building: Open Discussion Facilitators: Scott Leischow, Mayo Clinic; and Jim Thrasher, University of South Carolina 4:50 p.m. Adjourn for the Day Day 3 9:00 a.m. 1:00 p.m. 9:00 a.m. 1:00 p.m. Session 7: Identifying Research Priorities and Areas for Collaboration Chair: Toker Ergüder, WHO 9:00 a.m. 9:15 a.m. Review and Commentary: What Have We Learned? Facilitator: 9:15 a.m. 9:30 a.m. Coffee and Tea Break 9:30 a.m. 11:15 a.m. Breakout Groups: Identify Research Gaps and Priorities in Tobacco Control and Opportunities To Enhance Collaboration Facilitator(s): TBD 11:15 a.m. 12:15 p.m. Report and Discussion: Breakout Groups To Report Back and the Full Group To Develop a Common List of Recommendations for Collaborative Research Activities Facilitator(s): TBD 12:15 p.m. 1:00 p.m. Discussion of Next Steps Facilitators: and Nazmi Bilir, Hacettepe University 1:00 p.m. Lunch and Adjournment 5